Worldwide Demand for Acid Reducers is Predicted to Reach US$ 40.3 Billion by 2033

The market for acid reducers is anticipated to be valued at US$ 23.1 billion in 2023 and to grow at a CAGR of 5.7% to US$ 40.3 billion by the end of 2033.

Download Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=8083

Adoption of acid reducers is relatively less owing to fears over the link to dementia in the aging population that consumes them. However, precision medicine advancements in the healthcare sector are changing the trend with rapid adoption.

Acid Reducer Market : Key Findings

• Rising Prevalence of Acid-related Disorders: The Acid Reducer market is experiencing significant growth due to the rising prevalence of acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and heartburn. Factors such as unhealthy dietary habits, sedentary lifestyles, and stress contribute to the increased incidence of these conditions, driving the demand for acid reducers.

• Increasing Awareness of Acid Reflux Symptoms: Growing awareness among individuals about the symptoms and complications associated with acid reflux has led to increased diagnosis and treatment. Acid reducers, also known as proton pump inhibitors (PPIs) and H2 blockers, are commonly prescribed to reduce stomach acid production and alleviate symptoms such as heartburn, regurgitation, and chest pain.

• Over-the-Counter (OTC) Availability: Many acid reducers are available over-the-counter without a prescription. This accessibility has contributed to the widespread use of acid reducers by individuals who self-diagnose and self-treat acid reflux symptoms. The OTC availability of acid reducers has also led to increased competition among manufacturers in the market.

• Growing Geriatric Population: The aging population is a significant driver of the Acid Reducer market. Older adults are more susceptible to acid-related disorders due to age-related changes in the digestive system, weakened esophageal sphincter muscles, and increased medication use. The growing geriatric population contributes to the increased demand for acid reducers.

• Preference for Non-invasive Treatment Options: Acid reducers are preferred by individuals who seek non-invasive treatment options for acid reflux and related conditions. These medications provide symptomatic relief and help prevent complications associated with chronic acid exposure, such as esophageal damage and ulcers. The convenience and effectiveness of acid reducers make them a popular choice for managing acid-related disorders.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=8083

Competitive Landscape

To introduce new innovative and dependable acid reducer products in the market, the key industry competitors are concentrating on enhancing their research and development operations. Moreover, it is anticipated that developing a variety of chewable pills in a range of flavors to increase patient adherence to the prescription will result in substantial income creation. In addition to this, the players are concentrating on inorganic growth tactics like mergers, acquisitions, and collaborations to strengthen their position in the market.

• In Nov 2021, Sanofi relaunched an OTC medication named 'Zantac 360°', which is a popular heartburn medication with famotidine as an active ingredient.

Key Companies Profiled:

• AdvaCare
• GlaxoSmithKline
• AstraZeneca
• Pfizer
• Johnson & Johnson
• Sanofi
• Reddy's Laboratories
• Glenmark Generics
• Apotex
• Sandoz

For in-depth competitive analysis, Buy Now:

https://www.factmr.com/checkout/8083

Segmentation of Acid Reducer Industry Research

• By Type :

o Histamine-2 Antagonists

 Famotidine
 Cimetidine
 Nizatidine
 Others

o Proton Pump Inhibitors

 Omeprazole
 lansoprazole
 Dexlansoprazole
 Esomeprazole
 Others

• By Form :

o Tablets
o Liquid
o Powder
o Others

• By Availability :

o OTC Drugs
o Rx Drugs

• By Distribution Channel :

o Online

 Brand Websites
 e-Commerce Platforms

o Offline

 Hospital Pharmacies
 Retail Pharmacies

Key Questions Covered in the Acid Reducer Market Report :

• What is the projected value of the Acid Reducer factors Industry in 2023?
• At what rate will the global Acid Reducer factors market size grow until 2033?
• Which are the factors hampering the growth of Acid Reducer factors?
• Which region is expected to lead in the global Acid Reducer factors market by 2033?
• Which are the factors driving the Acid Reducer factors Industry during the forecast period?
• What is the expected market value of the Acid Reducer factors market during the forecast period?

Regional Analysis for Keyword Market:

• APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (USA, Canada and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, United Arab Emirates, South Africa)

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of industry research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.